Diabetes Supplement Market Size, Share & Trends Analysis Report By Type of Supplement (Vitamins, Minerals, Proteins & Amino Acids, Antioxidant & Fatty Acids, Dietary Fibers, Others), By Form (Tablets, Capsules, Powders, Soft Gels, Liquids), By Product (Proteins & Amino Acids, Omega-3 Fatty Acids, Minerals & Vitamins, Alpha Lipoic Acid (ALA), Herbal Supplements, Soluble Fiber, Probiotics, Carbohydrates, Others), By Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Diabetes Supplement Market Size

The global diabetes supplement market size was valued at USD 16.01 billion in 2023 and is expected to reach a valuation of USD 38.09 billion by 2032. The market is expected to grow at a CAGR of 10.30% during the forecast period (2024–2032).

Anti-diabetic supplements are widely used for controlling the blood sugar level. It increases the cell’s ability to utilize excess glucose, boosts energy levels, speeds up the process of rejuvenation, improves the development of muscles, increases insulin production, and prevents abnormal weight loss. Currently, there are a number of anti-diabetic supplements available in the market, including Alpha-Lipoic Acid, Chromium, Cinnamon, Fenugreek, Probiotics, B Vitamins, and Vitamin D supplements. However, the stringent regulations guarding the manufacturing of diabetes supplements is likely to impede the market growth to some extent.

Globally, the prevalence of diabetes is increasing at an alarming rate. This can be attributed to the rising consumption of unhealthy food, sedentary lifestyle, growing obese population, and increasing prevalence of cholesterol, cardiac diseases, and auto-immune diseases. As per the International Diabetes Federation (IDF), in 2019, about 450 million people aged 20–79 were suffering from diabetes, and the number is expected to reach around 700 million by 2045. Also, about 79% of the diabetic population resides in low and middle-income countries. Additionally, the global economic cost of diabetes is expected to reach USD 2.5 trillion by 2030 and the global economic burden of diabetes is expected to increase by 88%. As per the American Diabetes Association, in the U.S., the cost of diabetes was valued at USD 327 billion in 2018.

Diabetes Supplement Market Trends

The global diabetes supplement market is expected to grow at a significant pace in the years to come on account of growing investments in the field by leading market players.

Preference of local brands over branded supplements

The consumers in the global market are inclined towards purchasing supplements from local brands than branded products due to its safety and efficacy issues. For instance, in India, the people are shifting towards the use of sugar-free, gluten-free, zero carb, and probiotics supplements developed by local players, such as Himalaya, Dabur, and Patanjali Ayurveda Limited, among others, which is further boosting the diabetes supplement market growth.

Growing adoption of e-commerce  

In the last few years, the consumers have been inclining towards the purchase of supplements from a number of online stores as they are convenient and have a wide variety of products to choose from in the comfort of home. In line with this, several market players—including Amway and Herbal Nutrition—are offering their products online and are providing umpteen services, including on-time delivery and free shipping.

Regional Analysis

Regionally, the global diabetes supplement market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa

North america

North America is grabbing one of the largest share in the global diabetes supplement market. This can be attributed to the increasing prevalence of prediabetes and obesity and the rising geriatric population. As per the CDC, in the U.S. alone, around 84.1 million people (33.9% of the population)  aged 18 and older suffered from prediabetes in 2015, and nearly 48.3% of the geriatric population suffered from prediabetes conditions. The U.S. is dominating the global market in North America. As per the Council for Responsible Nutrition (CRN), in the U.S., about 60% of the people consume diabetic supplements.

Europe

Europe is expected to be a leading region in the global diabetes supplement industry on account of the increasing prevalence of prediabetes and diabetes diseases, rising healthcare expenditure, growing consumption of unhealthy food, and rising prevalence of metabolic conditions. As per the British Diabetic Association, in 2017, around 3.1 million people suffered from diabetes. According to the International Diabetes Federation, Europe spent over USD 100 billion on diabetes in 2010, and the expenditure is expected to reach USD 125 billion by 2030.

Asia pacific

The Asia Pacific is the fastest-growing market for diabetes supplement. The region is housing the highest population suffering from diabetes and prediabetes diseases. To attend to the situation, the governments in the region are heavily investing in the healthcare sector to provide better treatment options, which is likely to boost the market growth to some extent. Additionally, the region is backed with the presence of leading contributors, i.e., China and India, where the population of diabetes is increasing at a concerning rate due to the rising prevalence of obesity and sedentary lifestyle. As per the National Urban Diabetes Survey, around 14% of the total population is suffering from diabetes in the region. Moreover, in India, the diabetic supplements market, including protein and herbal supplements, accounts for over 60% of the Indian market. This can be attributed to the increasing prevalence of chronic metabolic diseases and rising awareness regarding the maintenance of health among Indian consumers.

In China, around 47% of the population is suffering from prediabetes or diabetes, and the number is expected to grow by 2040. To attend to the dire situation, the government of China is heavily investing in the healthcare sector to provide better treatment options at reasonable prices. For instance, in 2018, the government of China invested around USD 105 billion in diabetes healthcare, as per the International Diabetes Federation (IDF).

South america

Increasing the diabetic population and lack of awareness regarding the complications related to diabetes is increasing the overall mortality rate across South American. For instance, around 10.6 million people were living with undiagnosed diabetes in South America, as per IDF 2018. To address the situation, South American countries, including Argentina, Brazil, and Colombia, are providing universal health coverage to the people, which is further boosting the market growth.

The middle east and africa

The Middle East and Africa is emerging in the global industry on account of the rapidly increasing prevalence of diabetes across the region. However, in the Middle East, growing urbanization, improving healthcare infrastructure, rising healthcare expenditure, and high disposable income are projected to drive the market growth to some extent. On the other hand, Africa holds the least share in the global market due to poor healthcare infrastructure, limited availability of funds, and low spending power in the region. However, the region is expected to gain momentum in the years to come on account of umpteen untapped opportunities.

Segmental Analysis

based on the form

The market is segmented into tablets, capsules, powders, soft gels, liquids, and others. The tablet segment is dominating the diabetes supplement market due to its cost-effectiveness and easy packaging. Additionally, it is highly favored as it provides better shelf life and possesses fast-dissolving properties.

Based on product type

The market is segmented into proteins & amino acids, omega-3 fatty acids, minerals & vitamins, alpha lipoic acid (ALA), herbal supplements, soluble fiber, probiotics, carbohydrates, and others.

The global market offers a variety of options for controlling blood sugar. Minerals and vitamins dominate the product segment, providing essential nutrients for cellular glucose uptake and overall health. Other options include protein, omega-3 and alpha-lipoic acid for cellular health and potential blood sugar control. Herbal supplements, soluble fiber, and probiotics can influence blood sugar control, gut health, and manage complications. Rounding out the market are specialized carbohydrates and other targeted options. With its focus on foundational support, the minerals and vitamins segment remain the dominant player.

Based on indication

The market is segmented into type 1 diabetes, type 2 diabetes, prediabetes, gestational diabetes.Supplements catering to different diabetes stages are available in the market. Type 2 diabetes is the most prevalent, and supplements aim to help manage blood sugar levels effectively. The prediabetes segment is on the rise as people look for ways to control their blood sugar and potentially prevent the progression of diabetes. For type 1 and gestational diabetes, there are smaller segments that provide specific support for these specific conditions.

Based on distribution channel

The market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. Dietary supplements for diabetes reach customers through various channels. Currently, retail pharmacies are dominating the distribution channel segment. This is because they offer convenient access, pharmacy advisors and a shopping experience familiar to many. However, online pharmacies have grown in popularity. Their wider selection, competitive pricing and ease of ordering at home is attracting a growing customer base. Hospital pharmacies and other channels, such as specialty stores, also have a role to play in serving specialty needs. As online options develop, distribution of diabetes supplements is likely to become even more dynamic.

Recent Developments

• The U.S. FDA approved first diabetic supplement glucagon-like peptide (GLP-1) to treat type 2 diabetes developed by Novo Nordisk
• Caelus Health and Nestlé Health Science signed an agreement on Caelus’ microbiome-based food supplements for early treatment and management of cardio-metabolic diseases, such as diabetes. The intention behind the agreement is to develop and market food supplements for early intervention and nutritional management of diabetes.
• Valbiotis announced a global strategic partnership with Nestlé Health Science for the development and commercialization of TOTUM-63, an active substance derived from plants with clinically established metabolic health effects on prediabetes.